The Nasdaq Stock Market ended the session with Amgen rising 2.04% to $224.81 on Friday, after five sequential sessions in a row of losses. The Nasdaq Stock Market jumped 0.92% to $12,205.80, after three consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.
Amgen today’s close was $224.81, 17.86% below its 52-week high of $264.97.
Amgen’s sales growth is 6.4% for the ongoing quarter and 3.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 6.3% and positive 1% for the next.
Year-on-year quarterly revenue growth grew by 12%, now sitting on 24.99B for the twelve trailing months.
Amgen’s stock is valued at $224.81 at 18:15 EST, way under its 52-week high of $264.97 and way above its 52-week low of $177.05.
Amgen’s worth is under its 50-day moving average of $229.80 and below its 200-day moving average of $238.67.